-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MbSPY1eqTRMj4JEdFjVgu4FJ7NXZIRocMmCu7AHJyOqCJpYSHOGlLvKiS2BdQTJT nRykZcvyFjZYwDz33IXnaw== 0000874015-08-000045.txt : 20080813 0000874015-08-000045.hdr.sgml : 20080813 20080813184753 ACCESSION NUMBER: 0000874015-08-000045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080811 FILED AS OF DATE: 20080813 DATE AS OF CHANGE: 20080813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT C FRANK CENTRAL INDEX KEY: 0001073387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 081014903 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-08-11 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073387 BENNETT C FRANK C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 Senior Vice President Common Stock 2008-08-11 2008-08-11 4 M 0 15000 12.9375 A 15537 D Common Stock 2008-08-11 2008-08-11 4 S 0 7500 18.524 D 8037 D Common Stock 2008-08-11 2008-08-11 4 S 0 7500 18.033 D 537 D Employee Stock Option (right to buy) 12.9375 2008-08-11 2008-08-11 4 M 0 15000 0 D 2003-01-01 2008-12-31 Common Stock 15000 0 D The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3-12-08. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3-12-08. Acquired as a result of exercising a stock option that was scheduled to expire on 12-31-08. /s/B. Lynne Parshall, Attorney-in-fact 2008-08-13 -----END PRIVACY-ENHANCED MESSAGE-----